Diabetic Ketoacidosis News and Research

RSS
Diabetic ketoacidosis – (DKA) or diabetic coma occurs when a diabetic does not properly balance their insulin intake with their diet or activity.
Valsartan delays progression to type 2 diabetes in IGT patients: NAVIGATOR study

Valsartan delays progression to type 2 diabetes in IGT patients: NAVIGATOR study

NDA for BYDUREON: FDA issues complete response letter

NDA for BYDUREON: FDA issues complete response letter

Bristol-Myers Squibb, AstraZeneca commence SAVOR-TIMI 53 trial of ONGLYZA for type 2 diabetes

Bristol-Myers Squibb, AstraZeneca commence SAVOR-TIMI 53 trial of ONGLYZA for type 2 diabetes

Tubing-Free Insulin Pump System improves glycemic control in diabetic patients

Tubing-Free Insulin Pump System improves glycemic control in diabetic patients

FDA approves Novo Nordisk's Victoza for type 2 diabetes

FDA approves Novo Nordisk's Victoza for type 2 diabetes

Positive results from study comparing exenatide once weekly to BYETTA

Positive results from study comparing exenatide once weekly to BYETTA

FDA update on BYETTA injection: Amylin Pharmaceuticals and Eli Lilly respond

FDA update on BYETTA injection: Amylin Pharmaceuticals and Eli Lilly respond

FDA approves an expanded indication for BYETTA injection

FDA approves an expanded indication for BYETTA injection

Children with history of diabetic ketoacidosis may have memory problems

Children with history of diabetic ketoacidosis may have memory problems

Study shows type 2 diabetes patients treated with ACTOplus met experience blood sugar reduction

Study shows type 2 diabetes patients treated with ACTOplus met experience blood sugar reduction

FDA approves Daiichi Sankyo's sNDA for Welchol

FDA approves Daiichi Sankyo's sNDA for Welchol

Januvia in combination with metformin or taken alone lowers blood sugar

Januvia in combination with metformin or taken alone lowers blood sugar

Safety profiles of JANUVIA and JANUMET drugs established through clinical development program

Safety profiles of JANUVIA and JANUMET drugs established through clinical development program

European CHMP recommends Merck's JANUVIA and JANUMET as add-on to insulin

European CHMP recommends Merck's JANUVIA and JANUMET as add-on to insulin

Takeda receives FDA response regarding NDA for fixed-dose combination of alogliptin and ACTOS

Takeda receives FDA response regarding NDA for fixed-dose combination of alogliptin and ACTOS

Every 3 minutes one person is diagnosed with diabetes

Every 3 minutes one person is diagnosed with diabetes

Parents who just prayed as child was dying charged with murder

Parents who just prayed as child was dying charged with murder

Tredaptive and Janumet recommended for approval in European Union

Tredaptive and Janumet recommended for approval in European Union

Efficient response in primary care would reduce the use of hospitals by seniors

Efficient response in primary care would reduce the use of hospitals by seniors

Restricting insulin doses increases mortality risk in women with type 1 diabetes

Restricting insulin doses increases mortality risk in women with type 1 diabetes